Synthesis and antimalarial activity of ethylene glycol oligomeric ethers of artemisinin

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 2, 2011, Pages 278-286

  Steyn, Minette ^a   N'Da, David D ^a   Breytenbach, Jaco C ^a   Smith, Peter J ^b   Meredith, Sandra ^b   Breytenbach, Wilma J ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

artemether; artemisinin; chloroquine; malaria; Plasmodium falciparum

Indexed keywords

2 (2 ETHOXYETHOXY)ETHOXY 10BETA DIHYDROARTEMISININ; 2 (2 METHOXYETHOXY)ETHOXY 10BETA DIHYDROARTEMISININ; 2 [2 (2 ETHOXYETHOXY)ETHOXY] 10BETA DIHYDROARTEMISININ; 2 [2 (2 METHOXYETHOXY)ETHOXY]ETHOXY 10ALPHA DIHYDROARTEMISININ; 2 [2 (2 METHOXYETHOXY)ETHOXY]ETHOXY 10BETA DIHYDROARTEMISININ; 2 ETHOXYETHOXY 10ALPHA DIHYDROARTEMISININ; 2 ETHOXYETHOXY 10BETA DIHYDROARTEMISININ; 2 METHOXYETHOXY 10BETA DIHYDROARTEMISININ; ARTEMETHER; ARTEMISININ DERIVATIVE; CHLOROQUINE; ETHYLENE GLYCOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SOLUBILITY; DRUG SYNTHESIS; IC 50; NONHUMAN; PHYSICAL CHEMISTRY; PLASMODIUM FALCIPARUM; REACTION ANALYSIS;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; ETHERS; ETHYLENE GLYCOLS; PLASMODIUM FALCIPARUM; SOLUBILITY;

EID: 78751542955     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01205.x     Document Type: Article

References (31)

1. Davis TM, et al. Artemisinin-based combination therapies for uncomplicated malaria. Med J Aus 2005; 182: 181-185.
2. Klayman DL,. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985; 228: 1049-1052.
3. Hien TT, White NJ,. Qinghaosu. Lancet 1993; 341: 603-608.
4. De Vries PJ, Dien TK,. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996; 52: 818-836.
5. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials. Clinical studies on the treatment of malaria with qinghaosu and its derivatives. J Tradit Chin Med 1982; 2: 45-50.
6. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials. The chemistry and synthesis of qinghaosu derivatives. J Tradit Chin Med 1982; 2: 9-16.
7. Lee IS, Hufford CD,. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther 1990; 48: 345-355.
8. Tongyin W, Ruchang X,. Clinical studies of treatment of falciparum malaria with artemether, a derivative of qinghaosu. J Tradit Chin Med 1985; 5: 240-242.
9. Yang QC, et al. The antimalarial and toxic effect of artesunate on animal models. J Tradit Chin Med 1982; 2: 99-103.
10. Ilett KF, Batty KT,. Artemisinin and its derivatives. In:, Yu VL, et al., eds. Antimicrobial Therapy and Vaccines. London: ESun Technologies LLC, 2004: 957-978.
11. Lin AJ, et al. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain. J Med Chem 1989; 32: 1249-1252.
12. Lin AJ, et al. Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4 (R or S)-[10 (α or β)-dihydroartemisininoxy] butyric acids. J Med Chem 1997; 40: 1396-1400.
13. Hamidi M, et al. Pharmacokinetic consequences of pegylation. Drug Del 2006; 13: 399-409.
14. Nucci ML, et al. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv Drug Del Rev 1991; 6: 133-151.
15. Harris JM, Chess RB,. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003; 2: 214-221.
16. Koumenis IL, et al. Modulating pharmacokinetics of an anti-interleukin-8 F (abâ) 2 by amine-specific PEGylation with preserved bioactivity. Int J Pharm 2000; 198: 83-95.
17. Monfardini C, et al. A branched monomethoxypoly(ethylene glycol) for protein modification. Bioconjug Chem 1995; 6: 62-69.
18. Kozlowski A, et al. Development of pegylated interferons for the treatment of chronic hepatitis C. BioDrugs 2001; 15: 419-429. (Pubitemid 32783703)
19. Li Y, et al. Synthesis and antimalarial activity of artemisinin derivatives containing an amino group. J Med Chem 2000; 43: 1635-1640.
20. Trager W, Jensen JB,. Human malaria parasites in continuous culture. Science 1976; 193: 673-676.
21. Makler MT, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg 1993; 48: 739-742.
22. Tabachnick BG, Fidell LS,. Using Multivariate Statistics, 4th edn. Boston, MA: Allyn & Bacon, 2001.
23. StatSoft Inc. Statistica (data analysis software system), version 8.0. 2007.
24. Venugopalan B, et al. Antimalarial activity of new ethers and thioethers of dihydroartemisinin. Eur J Med Chem 1995; 30: 697-706.
25. Venugopalan B, et al. Radical initiated reactions of artemisinin derivatives. J Chem Soc (Perkin 1) 1996; 10: 1015-1020. (Pubitemid 126801264)
26. Caron G, et al. Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects. Pharm Sci Technol Today 1999; 2: 327-335.
27. Lipinski CA, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46: 3-26.
28. Solomons TW, Fryhle CB,. Organic Chemistry, 9th edn. New York, NY: Wiley J & Sons, 2007.
29. N'Da DD, Breytenbach JC,. Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zudovudine and penetration through human skin in vitro. J Pharm Pharmacol 2009; 61: 721-731.
30. Warhurst DC, et al. The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Malaria J 2003; 2: 26.
31. Bigucci F, et al. Transport of fluoroalkyl dihydroartemisinin derivatives across rat intestinal tissue. J Pharm Pharmacol 2008; 60: 163-169.